48 GENES FOUND

? »

Limit search: Genes with antibodies | Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

Page of 1

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1BCalcium channel, voltage-dependent, N type, alpha 1B subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1DCalcium channel, voltage-dependent, L type, alpha 1D subunitCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Mixed
CACNA1FCalcium channel, voltage-dependent, L type, alpha 1F subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CACNA1GCalcium channel, voltage-dependent, T type, alpha 1G subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1HCalcium channel, voltage-dependent, T type, alpha 1H subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CACNA1ICalcium channel, voltage-dependent, T type, alpha 1I subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1SCalcium channel, voltage-dependent, L type, alpha 1S subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA1Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium voltage-gated channel, shaker-related subfamily, member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNA2Potassium voltage-gated channel, shaker-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA3Potassium voltage-gated channel, shaker-related subfamily, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium voltage-gated channel, shaker-related subfamily, member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium voltage-gated channel, shaker-related subfamily, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA6Potassium voltage-gated channel, shaker-related subfamily, member 6FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA7Potassium voltage-gated channel, shaker-related subfamily, member 7FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNB1Potassium voltage-gated channel, Shab-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB2Potassium voltage-gated channel, Shab-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNC1Potassium voltage-gated channel, Shaw-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC2Potassium voltage-gated channel, Shaw-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC3Potassium voltage-gated channel, Shaw-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCND1Potassium voltage-gated channel, Shal-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCND2Potassium voltage-gated channel, Shal-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel, Shal-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNH2Potassium voltage-gated channel, subfamily H (eag-related), member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ1Potassium inwardly-rectifying channel, subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ11Potassium inwardly-rectifying channel, subfamily J, member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNJ12Potassium inwardly-rectifying channel, subfamily J, member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNJ8Potassium inwardly-rectifying channel, subfamily J, member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK2Potassium channel, subfamily K, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNK3Potassium channel, subfamily K, member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK9Potassium channel, subfamily K, member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
KCNMA1Potassium large conductance calcium-activated channel, subfamily M, alpha member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNN4Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel, KQT-like subfamily, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel, KQT-like subfamily, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNQ3Potassium voltage-gated channel, KQT-like subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SCN10ASodium channel, voltage-gated, type X, alpha subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Not detected
SCN11ASodium channel, voltage-gated, type XI, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
SCN1ASodium channel, voltage-gated, type I, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
SCN2ASodium channel, voltage-gated, type II, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SCN3ASodium channel, voltage-gated, type III, alpha subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
SCN4ASodium channel, voltage-gated, type IV, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
SCN5ASodium channel, voltage-gated, type V, alpha subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SCN9ASodium channel, voltage-gated, type IX, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
TRPA1Transient receptor potential cation channel, subfamily A, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPM8Transient receptor potential cation channel, subfamily M, member 8FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Group enriched

Page of 1